Quarter Financials
NovaBay Pharmaceuticals, Inc. (NBY)
$1.61
+0.07 (+4.55%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
|---|
| Net Income | -0 | -2 | -0 | -0 | -2 | -2 | -2 | -2 |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | -150 | -144 | -142 | -142 | -142 | -139 | -138 | -136 |
|---|
|
Year
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
|---|
| Capital Expenditure | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
|---|
| Net PPE | 2 | 2 | 3 | 1 | 0 | 0 | 0 | 1 |
|---|
|
Year
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
|---|
| New Purchases | - | - | - | - | - | - | - | - |
|---|
| Intangible and Goodwill | - | - | - | - | 5 | 5 | 5 | 5 |
|---|